{"componentChunkName":"component---gatsby-theme-buzzing-src-gatsby-theme-blog-core-templates-post-query-js","path":"/en/reddit/r/stocks/comments/kjexi6/inovio_pharmaceuticals_ino4800_peer_review/","result":{"data":{"site":{"siteMetadata":{"title":"Reddit 热门","description":"用中文浏览Reddit热门内容","social":[{"name":"Reddit","url":"https://www.reddit.com/","external":true,"prefetch":null},{"name":"GitHub","url":"https://github.com/gatsbyjs","external":null,"prefetch":null}],"menuLinks":[{"name":"每周精选","url":"/issues","external":null,"prefetch":null},{"name":"RSS","url":"/rss.xml","external":null,"prefetch":false}],"localize":[{"title":"Buzzing on Reddit","description":"See what's buzzing on Reddit in your native language","locale":"en","social":[{"name":"Reddit","url":"https://www.reddit.com/","external":true,"prefetch":null}],"menuLinks":[{"name":"Weekly Selection","url":"/issues","external":null,"prefetch":null},{"name":"RSS","url":"/rss.xml","external":null,"prefetch":false}]},{"title":"Reddit 熱門","description":"用中文瀏覽Reddit熱門內容","locale":"zh-Hant","social":null,"menuLinks":null}]}},"blogPost":{"__typename":"SocialMediaPost","id":"RedditPost-kjexi6","excerpt":"Just released!\n\n * 100% cellular response in the 2 mg group\n * Grade 1 adverse side effects = Redness at injection site/erythema\n\nhttps://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30433-8/fulltext\n[https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20]30433-8/fulltext)","body":"<!-- SC_OFF --><div class=\"md\"><p>Just released!</p>\n\n<ul>\n<li>100% cellular response in the 2 mg group</li>\n<li>Grade 1 adverse side effects = Redness at injection site/erythema</li>\n</ul>\n\n<p><a href=\"https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20\">https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30433-8/fulltext</a>30433-8/fulltext)</p>\n</div><!-- SC_ON -->","slug":"/reddit/r/stocks/comments/kjexi6/inovio_pharmaceuticals_ino4800_peer_review/","title":"Inovio Pharmaceuticals INO-4800 Peer Review Released. 100% Efficacy.","tags":["stocks","reddit"],"date":"December 24, 2020","dateISO":"2020-12-24T14:38:56.000Z","datetime":"2020-12-24 14:38","image":null,"imageAlt":null,"socialImage":null,"fields":{"basePath":"/"},"thirdPartyId":"kjexi6","provider":"Reddit","url":"https://www.reddit.com/r/stocks/comments/kjexi6/inovio_pharmaceuticals_ino4800_peer_review/","originalUrl":"https://www.reddit.com/r/stocks/comments/kjexi6/inovio_pharmaceuticals_ino4800_peer_review/","imageRemote":null,"video":null,"channel":"stocks","channelUrl":"https://www.reddit.com/r/stocks","author":"returntrip1","authorUrl":"https://www.reddit.com/user/returntrip1","authorImage":null,"authorSlug":"returntrip1","score":241,"views":null,"sharedCount":null,"likeCount":null,"sharedContent":null,"parent":{"__typename":"RedditJson","localize":[{"title":"Inovio制药INO-4800同行评审发布。100%有效率。","the_new_excerpt":"刚刚被释放！\n\n*2毫克组细胞反应率为100%\n*一级不良反应=注射部位发红/红斑\n\nhttps://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30433-8/fulltext\n[https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20]30433-8/fulltext)","locale":"zh"},{"title":"Inovio製藥INO-4800同行評審發佈。100%有效率。","the_new_excerpt":"剛剛被釋放！\n\n*2毫克組細胞反應率爲100%\n*一級不良反應=注射部位發紅/紅斑\n\nhttps://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30433-8/fulltext\n[https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20]30433-8/fulltext)","locale":"zh-Hant"}]}},"previous":{"id":"TweetPost-1341880899428888584","excerpt":"","slug":"/tweet/1341880899428888584","title":"Tech leading all S&amp;P 500 sectors for the 2nd year in a row with a 43% gain.\n\nFollowing the 50% gain in 2019 this the 2nd best 2-year performance ever for Tech after 1998-1999.\n\n$XLK\n\nData via @ycharts https://t.co/Jo1z8zkBsw","date":"December 24, 2020","__typename":"SocialMediaPost","parent":{"__typename":"TweetJson","localize":[{"locale":"zh","full_text":"科技股以43%的涨幅连续第二年领跑所有标准普尔500指数板块。\n\n继2019年增长50%之后，这是Tech在1998-1999年后第二好的两年表现。\n\n$XLK\n\n通过@ycharts https://t.co/Jo1z8zkBsw提供的数据","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh-Hant","full_text":"科技股以43%的漲幅連續第二年領跑所有標準普爾500指數板塊。\n\n繼2019年增長50%之後，這是Tech在1998-1999年後第二好的兩年表現。\n\n$XLK\n\n通過@ycharts https://t.co/Jo1z8zkBsw提供的數據","quoted_status_full_text":null,"retweeted_status_full_text":null}]}},"next":{"id":"RedditPost-kjf1bj","excerpt":"Nikola saw another stock crash yesterday, while Alibaba’s stock plunges\nafter-hours with increased pressure from the regulators. Some news about DKNG,\nPENN and other stock market news for today.\n\n~Very Long Post~\n\nHello everyone and Good Morning! First of all, I wanted to wish to everyone\nhappiness,…","slug":"/reddit/r/stocks/comments/kjf1bj/nikola_stock_crash_alibaba_stock_plunges_dkng/","title":"Nikola Stock Crash | Alibaba Stock Plunges | DKNG & PENN | Stock Market News for Today [12-24]","__typename":"SocialMediaPost","date":"December 24, 2020","parent":{"__typename":"RedditJson","localize":[{"title":"尼古拉股灾|阿里巴巴股灾|DKNG&Penn|今日股市新闻[12-24]","the_new_excerpt":"尼古拉昨天再次出现股灾，而阿里巴巴的股价暴跌\n在监管机构压力加大的情况下，下班后。关于DKNG的一些消息，\n今天的宾夕法尼亚和其他股市消息。\n\n~很长的帖子~\n\n大家好，早上好！首先，我想祝大家\n快乐，…","locale":"zh"},{"title":"尼古拉股災|阿里巴巴股災|DKNG&Penn|今日股市新聞[12-24]","the_new_excerpt":"尼古拉昨天再次出現股災，而阿里巴巴的股價暴跌\n在監管機構壓力加大的情況下，下班後。關於DKNG的一些消息，\n今天的賓夕法尼亞和其他股市消息。\n\n~很長的帖子~\n\n大家好，早上好！首先，我想祝大家\n快樂，…","locale":"zh-Hant"}]}}},"pageContext":{"id":"RedditPost-kjexi6","previousId":"TweetPost-1341880899428888584","nextId":"RedditPost-kjf1bj","maxWidth":1024,"locale":"en","hrefLang":"en-US","originalPath":"/reddit/r/stocks/comments/kjexi6/inovio_pharmaceuticals_ino4800_peer_review/","dateFormat":"MM/DD/YYYY"}},"staticQueryHashes":["1239077767","2506312863","2744905544","3493603132","3493603132","386998304","4203388852"]}